论文部分内容阅读
Carumonam sodium系日本武田制药公司开发的单环β-内酰胺抗生素,对β-内酰胺酶稳定,特别是对包括绿脓杆菌的革蓝氏阴性菌抗菌作用强。结构式:
Carumonam sodium is a monocyclic β-lactam antibiotic developed by Takeda Pharmaceutical Co., Ltd. Japan. It is stable against β-lactamase, especially against Gram-negative bacteria including Pseudomonas aeruginosa. Structure: